The i-Pharm Competitor Insights Report for Q3 2024 provides a comprehensive analysis of the competitive landscape within the Life Sciences industry, focusing on the CDMOs, clinical trial services, and clinical trial technology sectors. This report, based on data sourced from LinkedIn, delivers a detailed examination of headcount trends across various companies, highlighting significant growth and strategic movements in employee numbers. Key insights include robust growth in drug product CDMOs, an uptick in hiring in the Cell & Gene Therapy sector following previous reductions, and notable increases in commercial headcounts within Trial Supplies & Logistics and Patient Recruitment sectors.  Designed to aid service and technology providers in the Life Sciences industry, the report offers valuable data for companies looking to expand their teams or gain a deeper understanding of industry trends.